PEG-MGDF

A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which is normally made in the body to help make platelets. PEG-MGDF is being studied as a way to increase the number of platelets in patients receiving chemotherapy. Also called PEG-rhMGDF and polyethylene glycosylated recombinant human megakaryocyte growth and development factor. (NCI Dictionary)

YOU MAY ALSO LIKE

PEG-linked L-RNA Oligonucleotide Hepcidin-targeting Agent NOX-H94

A proprietary 44-nucleotide L-stereoisomer RNA oligonucleotide conjugated to a 40 kDa polyethylene glycol (PEG) that targets hepcidin with potential anti-anemic activity. Upon…

PEG-Intron

A drug used to treat hepatitis C infections. PEG-Intron is a brand name for peginterferon alfa-2b. It is a type of…

PEG-interleukin-2

A complex of polyethylene glycol conjugated with human recombinant cytokine interleukin-2 (IL-2) with antineoplastic activity. PEG-interleukin-2 induces natural killer (NK) cell activity…

PEG-Glutaminase-Asparaginase

A pegylated form of glutaminase-asparaginase developed to decrease immunogenicity.

PEG-based Laxative NER1006

A preparation containing the nonabsorbable polymer polyethylene glycol (PEG or macrogol) 3350 with laxative activity. Upon oral administration, the PEG-3350-based laxative NER1006…

PEG-asparaginase

A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the drug asparaginase that is linked to a…